Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316134 · ClinicalTrials.gov registry record
Multiple Biomarkers in Undiagnosed Pleural Effusion
A clinical trial, sponsored by Fujirebio Diagnostics.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00316134: Clinical Trial study, sponsored by Fujirebio Diagnostics.
NCT00316134 is a clinical trial that was terminated before completion, run by Fujirebio Diagnostics. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00316134 was terminated before completion, sponsored by Fujirebio Diagnostics.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to evaluate the ability of various biomarkers measured in serum and/or pleural fluids to estimate the risk of finding cancer in patients with undiagnosed pleural effusions. An algorithm for prediction of the risk of finding cancer in the patient using an optimal combination of markers will be developed, and patients will be categorized as having a low, moderate, or high risk of finding cancer that might be used to more effectively triage patients.
Interventions
- PROCEDURE Procedure/Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-02 |
Why NCT00316134 stopped before completion
NCT00316134 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Procedure/Surgery is the first listed.
NCT00316134 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00316134 about?
NCT00316134 is a clinical study titled "Multiple Biomarkers in Undiagnosed Pleural Effusion". The purpose of this clinical trial is to evaluate the ability of various biomarkers measured in serum and/or pleural fluids to estimate the risk of finding cancer in patients with undiagnosed pleural effusions. An algorithm for prediction of the risk of finding cancer in the patient using an optimal...
What is the current status of trial NCT00316134?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2006-03. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00316134?
The interventions under investigation include: Procedure/Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00316134?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia